Combination therapy with an anti-hyaluronan agent and therapeutic agent
US10137104B2 · kind B2 · utility
1Cited by
116References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2017 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Jun 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is combination cancer therapy effected by administering a polymer-conjugated hyaluronidase, and a tumor-targeted taxane, and optionally a further chemotherapeutic agent such as a nucleoside analog. The combination therapy can be used in methods of treating cancers, and in particular solid tumor cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.